References list

• Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model.
  Ahmad, Gul, et al. Vaccine 2009 May 11;27: 2830-7
• Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta].
  Bharati, Kaushik, et al. Vaccine 2009 Jan 01;27: 10-6
• Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion.
  Bogers, Willy M, et al. J. Infect. Dis. 2015 Mar 15;211: 947-55
• Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens.
  Koopman, Gerrit, et al. J. Gen. Virol. 2004 Oct;85: 2915-24
• Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques.
  Kumar, Rakesh, et al. Virology 2006 Oct 10;354: 192-206
• Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates.
  Mooij, Petra, et al. J. Virol. 2008 Mar;82: 2975-88
• Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting.
  Rollier, Christine, et al. J. Infect. Dis. 2005 Sep 01;192: 920-9
• Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates.
  Verstrepen, Babs E, et al. Vaccine 2008 Jun 19;26: 3346-51
• Schistosoma mansoni antigen Sm-p80: prophylactic efficacy using TLR4 agonist vaccine adjuvant glucopyranosyl lipid A-Alum in murine and non-human primate models.
  Zhang, Weidong, et al. J. Investig. Med. 2018 Jul 10;: 1-9